Toggle navigation
Home
Search
Services
Blog
Contact
About
Support Services for Extramural Clinical Trials
Novak, Joel W.
Emmes Corporation, Rockville, MD, United States
Search 26 grants from Joel Novak
Search grants from Emmes Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Improving healthcare quality with user-centric patient portals
Surveillance of Serum Contents by Mast Cells and Regulation of Allergic Immunity
Mll Fusion Genes in Myeloid and Lymphoid Leukemias
Fibronectin mediated cell migration: signal integration
Neutrophil anti-inflammatory lipid signals
Recently added grants:
Molecular Basis of Pediatric Disease
Percutaneous Left Ventricular Unloading for Cardiogenic Shock: Beyond Acute Hemodynamic Support
Dissecting the role of vasopressin in regulating the critical period for social reward learning
Therapeutic Potential of ALK1 Activating Drugs in HHT Models
Birc5 as a regulator of NK cell development and immune function
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM017371-005
Application #
3609009
Study Section
Project Start
1981-09-29
Project End
1986-04-28
Budget Start
1987-12-04
Budget End
1986-04-28
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Emmes Corporation
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20850
Related projects
NIH 1986
N01 CM
Support Services for Extramural Clinical Trials
Novak, Joel W. / Emmes Corporation
NIH 1985
N01 CM
Support Services for Extramural Clinical Trials
Novak, Joel W. / Emmes Corporation
NIH 1985
N01 CM
Support Services for Extramural Clinical Trials
Novak, Joel W. / Emmes Corporation
Publications
Perloff, M; Killen, J Y; Wittes, R E
(1986)
Small cell bronchogenic carcinoma.
Curr Probl Cancer 10:169-214
Comments
Be the first to comment on this grant